The characteristics and survival of second primary lung cancer after Hodgkin's lymphoma: A comparison with first primary lung cancer using the SEER database

被引:1
|
作者
Lin, Ling [1 ]
Wang, Daquan [2 ]
Chen, Haizhu [3 ]
机构
[1] Tianjin Med Univ, Tianjin Baodi Hosp, Dept Oncol, Baodi Clin Coll, Tianjin, Peoples R China
[2] Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Breast Tumor Ctr,Dept Med Oncol,Phase Clin Trial C, Guangzhou, Peoples R China
来源
PLOS ONE | 2023年 / 18卷 / 05期
关键词
LONG-TERM SURVIVORS; DISEASE; RISK; CHEMOTHERAPY; MORTALITY; NEOPLASMS; THERAPY; TUMORS;
D O I
10.1371/journal.pone.0285766
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
ObjectiveThe study aimed to compare the characteristics and prognosis between patients with second primary lung cancer following Hodgkin's lymphoma and those with primary lung cancer. Materials and methodsUsing the SEER 18 database, the characteristics and prognosis were compared between the second primary non-small cell lung cancer following Hodgkin's lymphoma (HL-NSCLC) (n = 466) and the first primary non-small cell lung cancer (n = 469,851)(NSCLC-1), as well as between the second primary small cell lung cancer following Hodgkin's lymphoma (n = 93) (HL-SCLC) and the first primary small cell lung cancer (n = 94,168) (SCLC-1). Comparisons of categorical variables were performed using Chi-square or Fisher's test. Continuous variables were compared using the Mann-Whitney U test. Overall survival (OS) was estimated using the Kaplan-Meier method, and the difference between groups was analyzed by log-rank test. ResultsHL-NSCLC group had more males than NSCLC-1 group, and the median age of HL-NSCLC group was younger than that of NSCLC-1 group. Patients with HL-NSCLC showed inferior OS than those with NSCLC-1 (median: 10 months vs. 11 months, P = 0.006). Both HL-SCLC and SCLC-1 groups had poor prognosis, with median OS of 7 months (P = 0.4). The 3-year cumulative risks of death from any cause for patients with the latencies from HL to NSCLC of 0 to 5 years, >5 to 10 years, >10 to 15 years, >15 to 20 years, and>20 years were 71.8%, 82.6%, 86.8%, 85.7% and 78.5%, respectively(P = 0.020). ConclusionHL-NSCLC patients had worse prognosis than NSCLC-1 patients, while HL-SCLC patients shared similar characteristics and survival with SCLC-1 patients.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Survival of Patients with First and Metachronous Second Primary Breast Cancer or Lung Cancer Malignancy: Comparisons Using the SEER Database
    Miaochun Zhong
    Xianghong He
    Kefeng Lei
    [J]. Advances in Therapy, 2020, 37 : 2236 - 2245
  • [2] Survival of Patients with First and Metachronous Second Primary Breast Cancer or Lung Cancer Malignancy: Comparisons Using the SEER Database
    Zhong, Miaochun
    He, Xianghong
    Lei, Kefeng
    [J]. ADVANCES IN THERAPY, 2020, 37 (05) : 2236 - 2245
  • [3] Survival after second primary lung cancer
    Milano, Michael T.
    Li, Huilin
    Constine, Louis S.
    Travis, Lois B.
    [J]. CANCER, 2011, 117 (24) : 5538 - 5547
  • [4] Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients
    Milano, Michael T.
    Li, Huilin
    Constine, Louis S.
    Travis, Lois B.
    [J]. JOURNAL OF THORACIC DISEASE, 2012, 4 (01) : 22 - 29
  • [5] The Survival Impact of Second Primary Lung Cancer in Patients with Lung Cancer
    Choi, E.
    Luo, S.
    Aredo, J.
    Wilkens, L.
    Leung, A.
    Le Marchand, L.
    Cheng, I.
    Wakelee, H.
    Han, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [6] The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer
    Choi, Eunji
    Luo, Sophia J.
    Aredo, Jacqueline, V
    Backhus, Leah M.
    Wilkens, Lynne R.
    Su, Chloe C.
    Neal, Joel W.
    Le Marchand, Loic
    Cheng, Iona
    Wakelee, Heather A.
    Han, Summer S.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (04) : 618 - 625
  • [7] Experience of Third Primary Lung Tumors after Treatment of First and Second Primary Lung Cancer
    Watanabe, Takehiro
    Koizumi, Takahisa
    Hirono, Tatsuhiko
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S776 - S776
  • [8] Analysis of Second Primary Lung Cancers in the SEER Database
    Bhaskarla, Amrit
    Tang, Paul C.
    Mashtare, Terry
    Nwogu, Chukwumere E.
    Demmy, Todd L.
    Adjei, Alex A.
    Reid, Mary E.
    Yendamuri, Sai
    [J]. JOURNAL OF SURGICAL RESEARCH, 2010, 162 (01) : 1 - 6
  • [9] Images in two prostate cancer patients of second primary cancers: Hodgkin's lymphoma and lung adenocarcinoma
    Cegla, P.
    Wierzchoslawska, E.
    Marszalek, A.
    Gwozdz, S.
    Cholewinski, W.
    [J]. HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2018, 21 (03): : 221 - 223
  • [10] Microsatellite instability in second primary breast and lung cancer following treatment for Hodgkin lymphoma
    Scott, Kathryn
    Travis, Lois B.
    Scott, Daniel
    Dores, Graca M.
    Richman, Susan D.
    Seymour, Matthew T.
    Holowaty, Eric
    Glimelius, Bengt
    Andersson, Michael
    Pukkala, Eero
    Lynch, Charles F.
    Storm, Hans
    Allan, James M.
    [J]. CANCER RESEARCH, 2006, 66 (08)